New Findings on Blood Vessel Regulation
Gregory Schwartz, PhD, an RPB Career Development Award recipient, and his research collaborators at Northwestern University School of Medicine, recently published important discoveries related to blood vessel regulation in the journal Neuron. They identified nitric oxide-releasing amacrine cells as critical to blood vessel regulation in the retina and beyond.
The findings could impact diseases involving blood flow, such as diabetic retinopathy (DR). By detecting damage to nitric oxide-releasing amacrine cells, DR could potentially be diagnosed years earlier than is currently possible—before damage occurs. The knowledge gained through this research could even lead to new options for stroke treatment.
November 27, 2018
Related News: Diabetic Retinopathy, Feature Story, Retina Disorders , stroke, Top Story
Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine
Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.
RPB and Partners Award $1.2 Million In Grants for Novel AMD Research
Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.
The Career Development Award Turns 30: Celebrating a Generation of Support for Early-Career Scientists
CDA founded 30 years ago as one of the few private sources of funding aimed specifically at early-career vision researchers.
Could An Eye Exam Reveal Alzheimer’s Disease?
Study from RPB-supported researchers at Duke University suggests loss of blood vessels in retina reflect changes in brain health.
RPB-SUPPORTED RESEARCHERS INTEGRAL TO NEI’S AUDACIOUS GOALS INITIATIVE
Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS
(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
|
About RPBMission & HistoryMembershipSupport Us
|
|
|
e
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2019 Research to Prevent Blindness. All Rights Reserved.
